Examples of using
Active-controlled
in English and their translations into Croatian
{-}
Colloquial
Ecclesiastic
Computer
placebo and active-controlled clinical studies with Exelon transdermal patches for a duration of 24-48 weeks and from post-marketing data.
placebom i aktivno kontroliranim kliničkim ispitivanjima s Exelon transdermalnim flasterom u trajanju od 24-48 tjedana te iz podataka nakon stavljanja lijeka u promet.
parallel-group, active-controlled with Zinbryta 150 mg every 4 weeks(n=919)
randomizirano, aktivnim lijekom kontrolirano ispitivanje usporednih skupina sa Zinbrytom od 150 mg svaka 4 tjedna(n 919)
The efficacy and safety of Numient in patients with advanced stage Parkinson's disease have been evaluated in 2 double-blind, active-controlled studies: parallel study ADVANCE-PD(study IPX066-B09-02; 22 weeks) and cross-over study ASCEND-PD study IPX066-B-09-06 Part 1; 11 weeks.
Djelotvornot i sigurnost Numienta u bolesnika s uznapredovalom Parkinsonovom bolešću procijenjene su u dva dvostruko slijepa ispitivanja s aktivnom kontrolom: paralelno ispitivanje ADVANCE-PD(ispitivanje IPX066-B09-02; 22 tjedna) i ukriženo ispitivanje ASCEND-PD ispitivanjeIPX066-B-09- 06 1. dio, 11 tjedana.
The first pivotal(phase III) clinical study XM22-03 was an active-controlled study in 202 patients with stage II-IV breast cancer receiving up to 4 cycles of chemotherapy consisting of doxorubicin and docetaxel.
Prvo glavno(faze III) kliničko ispitivanje XM22-03 bilo je ispitivanje s aktivnom kontrolom u kojem je 202 bolesnika s karcinomom dojke stadija II-IV primalo do 4 ciklusa kemoterapije koja se je sastojala od doksorubicina i docetaksela.
serological responses after 48 weeks of treatment in active-controlled clinical trials of 1,633 adults with chronic hepatitis B infection,
seroloških odgovora nakon 48 tjedana liječenja u aktivno kontroliranim kliničkim ispitivanjima 1633 odrasla bolesnika s infekcijom kroničnim hepatitisom B,
was evaluated in a multicenter, randomized, double-blind, active-controlled, 8-week, parallel-arm study.
dvostruko slijepom ispitivanju s aktivnom kontrolom, u trajanju od 8 tjedana, s paralelnom skupinom.
with Ilaris in the active-controlled clinical studies versus the comparator(7.7%)
s Ilarisom u aktivno kontroliranim kliničkim ispitivanjima
stratified, active-controlled study of 833 men and women aged 18-85 years mean age for men.
dvostruko-slijepom, stratificiranom ispitivanju s aktivnom kontrolom u.
in metastatic carcinoma of the colon or rectum were studied in three randomised, active-controlled clinical trials in combination with fluoropyrimidine-based first-line chemotherapy.
rektuma ispitane su u tri randomizirana, aktivno kontrolirana klinička ispitivanja u kombinaciji s kemoterapijom prve linije baziranom na fluoropirimidinu.
The safety population of Gilenya is derived from two Phase III placebo-controlled clinical studies and one Phase III active-controlled clinical study in patients with relapsing remitting multiple sclerosis.
Populacija za za ocjenu sigurnosti primjene lijeka Gilenya izvedena je iz dva placebom kontrolirana klinička ispitivanja faze III i jednog aktivno kontroliranog kliničkog ispitivanja faze III u bolesnika s relapsno remitirajućom multiplom sklerozom.
This was a phase III randomised, active-controlled, open-label trial investigating Avastin 10 mg/kg in combination with leucovorin with 5-fluorouracil bolus
Riječ je o randomiziranom, aktivno kontroliranom, otvorenom kliničkom ispitivanju faze III u kojemu se ispitivao Avastin u dozi od 10 mg/kg svaka 2 tjedna u kombinaciji s leukovorinom
In a double-blind, randomized, active-controlled clinical study of 516 patients with invasive fungal disease caused by Aspergillus species or other filamentous fungi, elevated liver transaminases(alanine aminotransferase
U dvostruko-slijepom, randomiziranom, aktivnim lijekom kontroliranom kliničkom ispitivanju s 516 bolesnika s invazivnom gljivičnom bolesti uzrokovanom vrstama Aspergillus ili drugim filamentoznim gljivicama,
one long-term double-blind, active-controlled, non-inferiority study.
dugotrajnom dvostruko slijepom, aktivno kontroliranom ispitivanju neinferiornosti.
double-blind, active-controlled clinical study used the recommended dose of 400 mg twice daily in combination with a fixed dose of emtricitabine 200 mg(+) tenofovir 245 mg in 281 patients, in comparison to 282 patients taking efavirenz(EFV)
dvostruko slijepom, aktivnim lijekom kontroliranom kliničkom ispitivanju u bolesnika koji prethodno nisu bili liječeni 281 bolesnik primao je preporučenu dozu od 400 mg lijeka ISENTRESS dvaput na dan u kombinaciji s fiksnom dozom od 200 mg emtricitabina(+) 245 mg tenofovira,
in a 4-way crossover, double-blind, placebo- and active-controlled(moxifloxacin 400 mg)
dvoslijepom ispitivanju s kontrolom placeba i aktivne kontrole(moksifloksacin 400 mg)
double-blind, active-controlled, parallel group study,
dvostruko-slijepoj, aktivno kontroliranoj studiji na paralelnim skupinama,
double-blind, active-controlled studies in patients with frequent gouty arthritis(≥ 3 attacks in the previous 12 months) unable to use NSAIDs
dvostruko slijepa, aktivno kontrolirana ispitivanja kod bolesnika s učestalim uričnim artritisom(≥3 napada u prethodnih 12 mjeseci) koji nisu mogli koristiti NSAIL-ove
received silodosin 8 mg once daily in two Phase III placebo-controlled clinical studies conducted in the United States and in one placebo- and active-controlled clinical study conducted in Europe.
mg jedanput na dan, u dva placebom kontrolirana klinička ispitivanja faze III koja su se provela u Sjedinjenim Američkim Državama i jednom kliničkom ispitivanju s placebom i aktivnom kontrolom provedenima u Europi.
evaluated in a randomised, placebo- and active-controlled(moxifloxacin 400 mg),
randomiziranom ispitivanju s placebom i aktivnom kontrolom(moksifloksacin od 400 mg),
In FLAMINGO(ING114915), an open-label, randomised and active-controlled study, 484 HIV-1 infected antiretroviral naïve adults received one dose of either dolutegravir 50 mg once daily(n=242)
U otvorenom, randomiziranom i aktivno kontroliranom ispitivanju FLAMINGO(ING114915), 484 odrasle osobe s HIV-1 infekcijom koje prethodno nisu bile liječene antiretrovirusnim lijekovima primile su jednu
Hrvatski
Deutsch
Italiano
عربى
Български
বাংলা
Český
Dansk
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Magyar
Bahasa indonesia
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文